Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 106, Issue 1, 1993, Pages 80-89

  Macchiarini, P ^a   Fontanini, G ^a   Hardin, M J ^a   Chuanchieh, H ^a   Bigini, D ^a   Vignati, S ^a   Pingitore, R ^a   Angeletti, C A ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH VESSEL; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

EID: 0027326034     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)33743-2     Document Type: Article

References (61)

1. Shields TW Carcinoma of the lung Shields TW General thoracic surgery 3rd ed 1989 Lea & Febiger Philadelphia 890 934
2. Read RC Yoder G Schaeffer RC Survival after conservative resection for T1 N0 M0 non-small cell lung cancer Ann Thorac Surg 49 1990 391 400
3. Thomas P Rubinstein L, and the Lung Cancer Study Group Cancer recurrence after resection: T1 N0 non-small cell lung cancer Ann Thorac Surg 49 1990 242 247
4. Holmes EC Bleehen NM Le Chevalier T Postoperative adjuvant treatments for non-small cell lung cancers: a consensus report Lung Cancer 7 1991 1 13
5. Gail MH Eagan RT Feld R Prognostic factors in patients with resected stage I non-small cell lung cancer Cancer 54 1984 1802 1813
6. Thomas PA Piantadosi S Postoperative T1 N0 non-small cell lung cancer J T horac C ardiovasc S urg 94 1987 349 354
7. Fontanini G, Macchiarini P, Pepe S, et al. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer [In press].
8. Cibas ES Melamed MR Zaman MB Kimmel M The effect of tumour size and tumour cell DNA content on the survival of patients with stage I adenocarcinoma of the lung Cancer 63 1989 1552 1556
9. Silvestrini R Muscolino G Costa A Could cell kinetics be a predictor of prognosis in non-small cell lung cancer? Lung Cancer 7 1991 165 170
10. Fontanini G, Pingitore R, Bigini D, et al. Growth fraction estimation in non-small cell lung cancer determined by proliferating cell nuclear antigen and comparison with the Ki-67 labeling and flow cytometry data. Am J Pathol [In press].
11. Maki E Feld R Prognostic factors in patients with non-small cell lung cancer. A critique of the world literature Lung Cancer 7 1991 27 34
12. Goldman L Caldera DL Nussbaum SR Multifactorial risk of cardiac risk in noncardiac surgical procedures N Engl J Med 297 1977 845 850
13. Macchiarini P Janni A Silvano G Mussi A Chella A Angeletti CA Results of treatments and lessons learned from pathologically staged T4 non-small cell lung cancer J Surg Oncol 47 1991 209 214
14. Macchiarini P Fontanini G Hardin JM Pingitore R Angeletti CA Most peripheral, node-negative non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion: rationale for treatment with wedge resection alone J T horac C ardiovasc S urg 104 1992 892 899
15. Mountain CF A new international staging system for lung cancer Chest 89 1986 225S 233S
16. World Health Organization The World Health Organization. Histological typing of lung tumors Am J Clinic Pathol 77 1982 123 136
17. Hsu SM Raine L The use of avidin-biotin peroxidase complex (ABC) in diagnostic and research pathology DeLessis RA Advances in immunohistochemistry 1984 Masson New York 31 42
18. Lee AKC DeLellis RA Silverman ML Heatley GI Wolfe HJ Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast J Clin Oncol 8 1990 1457 1465
19. Rosen PP Tumor emboli in intramammary lymphatics in breast cancer: pathological criteria for diagnosis and clinical significance Pathol Annu 18 1983 215 232 (part 2)
20. Weigand RA Isenberg WM Russo J Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer Cancer 50 1982 962 969
21. Bravo R Celis JE A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells J Cell Biol 84 1980 795 802
22. Bravo R Frank R Blundell PA MacDonald-Bravo H Cyclin/PCNA is the auxiliary protein of DNA polymerase alpha Nature 326 1987 515 517
23. Kurki P Ogata K Tan EM Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry J Immunol Methods 109 1988 49 59
24. Hall PA Levison DA Woods AL Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms J Pathol 162 1990 285 294
25. Waseem NH Lane DP Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form J Cell Sci 96 1990 121 129
26. Quinn CM Wright NA The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables J Pathol 160 1990 93 102
27. Kaplan EL Meier P Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
28. Peto R Pike MC Armitage P Breslow NE Cox DR Howard SY Design and analysis of randomized clinical trials requiring prolonged observations of each patient: II. Analysis and examples Br J Cancer 35 1977 1 39
29. Cox DR Regression models in life tables J R Stat Assoc [B] 34 1972 187 220
30. Kalbfleish JD Prentice RL The statistical analysis of failure time data 1980 Wiley New York
31. Kahn HA Sempos CT Statistical methods in epidemiology 1989 Oxford University New York 45 71
32. Sackett DL Haynes RB Tugwell P Clinical epidemiology: a basic science for clinical medicine 1985 Little, Brown Boston 47 138
33. Rosner B Fundamentals in biostatistics 3rd ed 1990 PWS-Kent Publisher Boston 42 70
34. Levine MN Browman GP Roberts R Goodyear M When is a prognostic factor useful? A guide for the perplexed J Clin Oncol 9 1991 348 356
35. Hoffmann TH Ransdell HT Comparison of lobectomy and wedge resection for carcinoma of the lung J T horac C ardiovasc S urg 79 1980 211 217
36. Williams DE Pairolero PC Davis CS Survival of patients surgically treated for stage I lung cancer J T horac C ardiovasc S urg 82 1981 70 76
37. Feld R Rubenstein LV Weisenberger TH Sites of recurrence in resected stage I-non-small cell lung cancer: a guide for future studies J Clin Oncol 2 1984 1352 1358
38. Read RC Schaefer R Walls R Diameter, cell type and survival in stage I primary non-small cell lung cancer Arch Surg 123 1988 446 449
39. Takise A Kodama T Shimosato Y Watanabe S Suemasu K Histologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter Cancer 61 1988 2083 2088
40. Roeslin N Chalkiadaakis G Dumont P Witz JP A better prognostic value from a modification of lung cancer staging J T horac C ardiovasc S urg 94 1987 504 509
41. Folkman J What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82 1990 2 4
42. Weiss W Boucot KR Cooper DA Survival of men with peripheral lung cancer in relation to histologic characteristics and growth rate Am Rev Respir Dis 98 1968 75 86
43. James RD Davey AT Mitotic index in carcinoma of the lung Lancet 20 1979 852
44. Merkel DE McGuire WL Ploidy, proliferative activity and prognosis Cancer 65 1990 1194 1205
45. Weidner N Semple JP William RW Folkman J Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma N Engl J Med 324 1991 1 8
46. Sillman F Boyce J Fruchter R The significance of atypical vessels and neovascularization in cervical neoplasia Am J Obstet Gynecol 139 1981 154 159
47. Chodak GW Haudenschild C Gittes RF Folkman J Angiogenic activity as a marker of neoplastic and of preneoplastic lesions of the human bladder Ann Surg 192 1980 762 771
48. Jensen HM Chen I deVault MR Lewis AR Angiogenesis induced by “normal” human breast tissue: a probable marker for precancer Science 218 1982 293 295
49. Fidler IJ Gersten DM Hart IR The biology of cancer invasion and metastasis Adv Cancer Res 28 1978 149 250
50. Liotta LA Saidel G Kleinerman J The significance of hematogenous tumour cell clumps in the metastatic process Cancer Res 36 1976 889 894
51. Srivastava A Laidler P Davies RP Horgan K Hughes LE The prognostic significance of tumour vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma: a quantitative histologic study Am J Pathol 133 1988 419 423
52. Liotta L Kleinerman J Saidel G Quantitative relationships of intravascular tumour cells, tumour vessels, and pulmonary metastases following tumour implantation Cancer Res 34 1974 997 1004
53. Ten Velde GPM Schutte B Vermeulen A Volovics A Reynders MMJ Blijham GH Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small cell lung cancer Eur J Cancer Clin Oncol 24 1988 455 460
54. Mountain CF Lukeman JM Hammer SP Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population J Surg Oncol 35 1987 147 156
55. Tockman MS Gupta PK Myers JD Sensitive and specific monoclonal recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection J Clin Oncol 6 1988 1685 1693
56. Fisher B Redmond C Dimitrov NV A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen receptor negative tumours N Engl J Med 320 1989 473 478
57. Mansour EG Gray R Shatila AH Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer N Engl J Med 320 1989 485 490
58. The Ludwig Breast Cancer Study Group Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer N Engl J Med 320 1989 491 496
59. Macchiarini P Hardin M Angeletti CA Long-term evaluation of intrapleural bacillus Calmette-Guerin with or without adjuvant chemotherapy in completely resected stages II and III non-small cell lung cancer Am J Clin Oncol 14 1991 291 297
60. Shields TW The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung J T horac C ardiovasc S urg 99 1990 48 53
61. Denekamp J Vascular attack as a therapeutic strategy for cancer Cancer Metastasis Rev 9 1990 267 282